Log In
BCIQ
Print this Print this
 

Sodium-glucose cotransporter 2 (SGLT2)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Sodium-glucose cotransporter 2 (SGLT2)

BCIQ
Print ChartPrint this
Marketed, 8 Approved, 3 Registration, 2 Phase IV, 1 Phase III, 1 Phase III, 3 Phase II/III, 1 Phase II, 1 Phase II, 4 Phase I, 1 Preclinical, 1 Preclinical, 1
Phase of DevelopmentPreclinicalPhase IPhase IIPhase II/IIIPhase IIIPhase IVRegistrationApprovedMarketed
Endocrine / Metabolic

1

1

4

1

3

-

2

3

8

Hepatic

1

-

1

-

-

-

-

-

-

Renal

-

-

-

-

1

1

-

-

-




 Products Targeting Sodium-glucose cotransporter 2 (SGLT2)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

15

$4,439.4M

$698.2M

$3,038.9M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today